TAIWAN · TWSE / TPEx
HNMC
禾榮科 · 7799 · TWSE (main board) · Biotech and medical
Share price, 2026-10-19NT$436.501 month +5.1% · 1 year -28.4%
Directors and supervisors hold67,266,25042.5% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold66,346,85941.9% of shares issued
Revenue, 2026-09-27.0%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 鋐享捷悅股份有限公司 | Chairman | 919,391 | 919,391 | 0.58% | — | — |
| 許金榮 | Chairman (corporate representative) | — | 0 | — | — | — |
| 勝璽投資股份有限公司 | Director · Major shareholder (10%+) | 17,377,071 | 17,377,071 | 10.98% | — | — |
| 陳迎璞 | Director (corporate representative) | — | 0 | — | — | — |
| 漢信股份有限公司 | Director · Major shareholder (10%+) | 21,009,000 | 21,009,000 | 13.28% | — | — |
| 林淑玲 | Director (corporate representative) | — | 0 | — | — | — |
| 漢信投資股份有限公司 | Director · Major shareholder (10%+) | 27,960,788 | 27,960,788 | 17.67% | — | — |
| 黃民奇 | Director (corporate representative) | — | 0 | — | — | — |
| 楊千 | Independent director | — | 0 | — | — | — |
| 謝昌辰 | Independent director | — | 0 | — | — | — |
| 鄭雅方 | Independent director | — | 0 | — | — | — |
| 沈孝廉 | President | — | 592,000 | 0.37% | — | — |
| 王文振 | Vice president · Chief financial officer · Chief accountant | — | 318,000 | 0.20% | — | 20,000 |
| 林正崧 | Vice president | — | 380,000 | 0.24% | — | — |
| 吳彥達 | Vice president | — | 385,000 | 0.24% | 224,000 | — |
| 陳韋霖 | Vice president | — | 464,019 | 0.29% | — | — |
Exchange announcements
| Date | |
|---|---|
| 2026-10-17 | 本公司與GE Precision Healthcare LLC簽署合作協議 |